🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Gemcitabine plus S-1 (GS) prolonged progression-free survival (PFS) and gre...
Status
Completed
Location
First affiliated hospital, Zhejiang University
Start Date
2014-01-01
Trial ID
NCT03869294
Treatments Being Tested
This study will conduct a phase II study of gemcitabine, erlotinib, and S-1...
Status
Completed
Location
Hallym University Medical Center
Start Date
2011-08
Trial ID
NCT01693419
Treatments Being Tested
Multiple centers, uncontrolled, open-label, non-randomized single-arm study...
Status
Completed
Location
China Medical University Hospital
Start Date
2018-04-03
Trial ID
NCT03559348
Treatments Being Tested
A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cis...
Status
Unknown
Location
Xiaozhong Chen
Start Date
2016-08
Trial ID
NCT02878889
Treatments Being Tested
This study is a prospective, open-label, randomized controlled trial that e...
Status
Recruiting
Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2025-01-25
Trial ID
NCT06789679
Treatments Being Tested
The purpose of this study is to find the best model of combination of intra...
Status
Unknown
Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2016-02
Trial ID
NCT02734680
Treatments Being Tested
RATIONALE: Studying samples of tumor tissue and blood from patients with ca...
Status
Terminated
Location
University of California, San Francisco
Start Date
2007-01-22
Trial ID
NCT00429858
Treatments Being Tested
This study is designed to explore the efficacy and safety of surufatinib co...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2021-08-04
Trial ID
NCT05218889
Treatments Being Tested
Phase I part, Primary objective: the maximum tolerated dose of S-1 in the S...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2012-03
Trial ID
NCT01415713
Treatments Being Tested
A randomized phase II study to compare the efficacy and safety of SLOG or m...
Status
Completed
Location
National Institute of Cancer Research
Start Date
2018-03-26
Trial ID
NCT03443492
Treatments Being Tested